Skip to main content

A Pioneer of The Multiplex Frontier

George Church is at it again, this time using multiplex gene editing to create virus-proof cells, improve organ transplant success, and protect elephants.

Written byRashmi ShivniBrought to you byDrug Discovery News
| 10 min read
Researchers in George Church&rsquo;s lab modified wild type ADK proteins (left) in <em>E.coli</em>, furnishing them with an nonstandard amino acid (nsAA) meant to biocontain the resulting bacterial strain.
Register for free to listen to this article
Listen with Speechify
0:00
10:00

At Harvard University’s Longwood campus, synthetic biologist and geneticist George Church finds himself busy. If he’s not guiding his students in building the latest biotech prototypes, he’s navigating new business ventures with his former ones.

Church is known for being a trailblazer in the bioengineering world. In some disciplines, he may be most popular for his work with direct genome sequencing and the Human Genome Project. In others, he and his students gained the spotlight by proving the capabilities of CRISPR-Cas9 editing in human cells. But the projects that his team is slogging away on now might have the next greatest impact on the scientific community at large.

“Our lab is sitting at an extreme point on the curve, and we’ve found that most times when we were out on the extreme, it's only a couple of years before we're overtaken by a tsunami of possibilities,” Church said.

This particular ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • Rashmi Shivni

    Rashmi is a freelance science writer with an MSc in microbiology from Northern Illinois University. She investigated the biochemistries of photosynthesis and whether we can find signs of microbial photosynthetic life on other worlds. She has a background in science journalism and hopes to continue making science accessible for all as she communicates her own research. Her writing appeared in PBS NewsHour, Audubon Magazine, Symmetry Magazine, and the Fermilab newsroom.

    View Full Profile

Related Topics

Related articles background image
The Scientist October Digest cover
October 2026

Antarctica’s Blood Falls Teems With Mysterious Microbial Life

Miles away from the closest ocean, marine microbes thrive in the red ice and mud around Blood Falls, offering clues to microbial adaptation and past climate events.

View this Issue
Evaluating Blood Biomarkers for Alzheimer’s Disease Staging

Evaluating Blood Biomarkers for Alzheimer’s Disease Staging

​Beckman Coulter
Find better biologics faster with Stunner and the AI Developability Workcell

Find better biologics faster with Stunner and the AI Developability Workcell

Unchained Labs
An image of microcentrifuge tubes arranged within colorful laboratory racks.

Choose clarity. Choose speed. Choose MyMass™

Refeyn
Characterizing LNP Heterogeneity With Super-Resolution Imaging

Characterizing LNP Heterogeneity With Super-Resolution Imaging

Oni

Products

Stellaromics Logo

Stellaromics Expands Pyxa Adoption as Instruments are Installed at Leading Research Institutions Across the U.S. and EuropeStellaromics, Inc., the leader in 3D

A monoclonal antibody surrounded by immune cells and red blood cells

CellRaft AIR: Find the Right Antibody-Producing Cells Faster

Cell Microsystems
Maxwell® Rapid ccfDNA Kit

Maxwell® Rapid ccfDNA Kit: Automated Purification of ccfDNA in Under 30 Minutes

Promega
Leica Biosystems, Tempus, and Paige logos side by side, marking the addition of Paige digital pathology AI tools to the Aperio AI Store.

Oncology Researchers Gain AI Cancer Tools in One Platform